A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
Status:
Completed
Trial end date:
2000-12-01
Target enrollment:
Participant gender:
Summary
Patients with superficial transitional cell carcinoma of the bladder will be treated with
intravesical suramin in a phase I dose escalating study. The toxicity of suramin administered
in this fashion will be evaluated.